Recombinant Human CHRNE Protein，His

CHRNE, or the cholinergic receptor nicotinic epsilon subunit, is a critical component of the nicotinic acetylcholine receptor (nAChR), which plays a significant role in neuromuscular transmission and neurotransmission in the central nervous system. Research on CHRNE is imperative due to its involvement in various physiological processes, and its implications in several neuromuscular disorders, such as congenital myasthenic syndromes and other autoimmune diseases like myasthenia gravis. Given the importance of nAChRs in mediating excitatory neurotransmission, CHRNE’s structural and functional characteristics are crucial for understanding receptor assembly, ion channel function, and receptor pharmacology. The recombinant expression of CHRNE in various systems, including mammalian cells and yeast, facilitates detailed analysis of its biophysical properties, ligand-binding characteristics, and interaction with other receptor subunits. This research not only advances our understanding of the fundamental biology of nicotinic receptors but also lays the groundwork for the development of targeted therapeutic strategies to treat diseases associated with nAChR dysfunction. Moreover, by investigating the structure and function of CHRNE, researchers aim to identify novel drug targets and improve existing treatment modalities for related neurological and muscular disorders, thereby enhancing therapeutic outcomes for affected patients.